CUROXEN: A Potential Game Changer in Combating Candida auris (and other drug-resistant bacteria and fungi)
Jun 23, 2023
Candida auris, a fungus that has emerged as a serious global health threat, is facing a new opponent - CUROXEN. OrganiCare, a leading manufacturer of topical over-the-counter (OTC) wound ointments, today announced an exciting development: CUROXEN has demonstrated the ability to kill more than 99.99% of this problematic fungus*.
The Unyielding Candida auris: A Rising Challenge in Global Health
C. auris (Candida auris), a relatively new entrant to the world of fungi, can cause severe infections and even result in death. What makes it particularly challenging is its resistance to many currently available antifungal medicines.1. It can cause serious illness and even death in 30 - 60% of immuno-compromised individuals2. The rising incidence and increasing resistance have led healthcare facilities and governmental bodies, including the CDC, to categorize C. auris as an urgent Antimicrobial Resistant (AR) threat3. In this race against time, novel treatments and strategies are urgently needed.
Image: Candida auris Culture: The Face of a Global Health Threat
CUROXEN, made with all-natural and organic ingredients, is an over-the-counter wound care ointment. The effectiveness of the CUROXEN product against C. auris has been tested by an independent, accredited laboratory using the ASTM E2315 suspension time-kill method and shown to eliminate 99.99% of the fungus*. CUROXEN has previously been tested and shown to eliminate other common and resistant microbes, such as MRSA, Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcus faecalis, and E. coli.
CUROXEN's Journey: From Italian Laboratories to Global Clinical SettingsDeveloped in Italy, CUROXEN is commonly used by physicians across Europe to treat difficult wounds in various clinical settings. Formulated using natural ingredients, it undergoes a unique process that forms peroxide bonds and oxygenates an olive oil-base, providing it with broad-spectrum antimicrobial and antifungal properties. These attributes can potentially protect against infection through various wounds, such as surgical incisions, feeding tubes, central lines, and pressure ulcers.
As the fight against C. auris intensifies, CUROXEN could become an indispensable tool for healthcare facilities. In a landscape dominated by petrochemical-based products, OrganiCare stands out with its commitment to creating safe, natural, and healthcare products that are more effective at killing resistant microbes than traditional drug prescriptions. CUROXEN offers a new and better approach to combating the persistent threat of C. auris.
Medical facilities must stop the spread of Candida auris, especially among the most vulnerable populations. By taking necessary precautions, staying informed, and supporting innovations like CUROXEN, we can make a difference in this global health challenge.
For more information about the revolutionary CUROXEN and its potential to fight Candida auris, please reach out to us directly at email@example.com.